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Abstract We previously reported that the reaction of [14C]S- 
ethylmaleimide (NEM) with the $65C mutant of the transposon 
Tnl0-encoded metal-tetracycline/H + antiporter (TetA(B)) is 
competitively inhibited by tetracycline [Yamaguchi, A. et al., 
FEBS Lett. 322 (1993) 201-204]. However, this observation has 
been revealed to be a mistake. The reaction of [14C]NEM with 
$65C TetA(B) was significantly and reproducibly accelerated by 
tetracycline, i.e. not inhibited. When Asp-66 was replaced by Ala, 
the reaction of NEM with the Cys-65 residue was no longer 
affected by tetracycline. In contrast, when Arg-70 was replaced 
by Ala, the acceleration of the reaction was unaltered. The tetra- 
cycline acceleration of the reaction to the Cys-65 residue was 
further stimulated with energization of the membrane on the 
addition of NADH. On the other hand, the tetracycline-induced 
acceleration was not observed in the absence of a divalent cation. 
These observations indicated that the Cys-65 locus is exposed to 
the medium according to the interaction of a divalent cation- 
tetracycline chelation complex with Asp-66. 
Key words: Antiporter; Tetracycline/H + antiporter; 
Site-directed mutagenesis; Sulfhydryl reagent 
I. Introduction 
The transposon Tnl0-encoded metal-tetracycline/H + an- 
tiporter (TetA(B)) contains a highly conserved sequence motif, 
GXXXDRXGRR,  in the putative cytoplasmic loop2 3 [2]. This 
motif  is conserved not only in the bacterial drug/H ÷ antiporters 
but also in the bacterial solute/H + symporters [3] and mammal- 
ian glucose transporters [4]. However, the precise role of this 
motif  remains unknown. We first studied the role of this motif  
by means of site-directed mutagenesis [2,5]. As a result, it was 
revealed that two glycines in this motif  are important for main- 
tenance of the loop structure [2]. In particular, Gly-69 is related 
to the b-turn structure of this loop. Asp-66 is the only acidic 
residue in this loop and the negative charge of its carboxyl side 
chain is essential for the function. The positive charge of Arg-70 
is also important for the function but the other two conserved 
arginines, Arg-67 and Arg-71, are not important for the activ- 
ity. Ser-65 is the residue just before the essential Asp-66 but is 
not important for the function [5]. However, when Ser-65 was 
replaced by Cys, the resulting $65C mutant was completely 
inactivated by N-ethylmaleimide (NEM) [5], whereas the activ- 
ity of neither the wild-type TetA(B) nor the other Cys mutants 
of this loop was affected by NEM [2]. The degree of the inacti- 
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vation of the $65C mutant by sulfhydryl reagents depended on 
the volume of the substituent [6], suggesting that the inactiva- 
tion is due to steric hindrance by the substituent. This was 
confirmed by the observation that the activity of the site-di- 
rected TetA(B) mutants was inversely proportional to the side 
chain volume of the residue at position 65 [6]. Finally, we 
observed that the reaction of [14C]NEM with the $65C mutant 
was competitively inhibited in the presence of tetracycline in the 
previous studies [1,6]. However, the last observation was a 
mistake. Later, we found that the reaction of [14C]NEM with 
the $65C mutant was not inhibited by tetracycline but rather 
significantly accelerated. In this study, we investigated the 
cause of the acceleration of the reaction of NEM by the sub- 
strate. 
2. Materials and methods 
2.1. Materials 
N-Ethyl[2,3-~4C]maleimide (333 MBq/mmol) and [7-3H(N)]tetracy - 
cline (23.7 GBq/mmol) were purchased from Amersham and DuPont- 
New England Nuclear, respectively. All other materials were of reagent 
grade and obtained from commercial sources. 
2.2. Plasmids 
pCT1183 [7] and pLGT2 [8] are high copy number and low copy 
number plasmids, respectively, containing tetA(B) and tetR(B) genes 
cloned from transposon Tnl0 [9]. pERS65C was constructed by sub- 
cloning a 485 bp EcoRV-EcoRI fragment of pLGS65C [5], which car- 
ries the $65C mutant etA(B) gene, into pUC118RV [8], in which the 
Sacl site of pUC118 [10] had been changed to an EeoRV site. In the 
resultant plasmid, the 5'-terminal half of the tetA(B) gene was cloned 
in the reverse direction. 
2.3. Construction of S65C/D66A and S65C/R70A doubh, mutants, and 
a D66C single mutant by site-directed mutagenesis 
Mutagenesis was performed by the oligonucleotide-directed site-spe- 
cific mutagenesis method of Kunkel [11]. Oligonucleotides were synthe- 
sized with a Cyclone Plus DNA/RNA Synthesizer (MiUiGen Biosearch 
Co.). The S65C/D66A double mutant was constructed using pERS65C, 
as a template, and a synthetic primer, 5'-AAATGTGCGCGCGATTT- 
GGT-3', which corresponds to the coding sequence containing mis- 
matches causing Ser-65 --+ Cys and Asp-66 --~ Ala mutations. The muta- 
tion was at first detected as the disappearance of the PvuI site, which 
exists in the corresponding sequence of pERS65C. After determination 
of the DNA sequence, the EeoRV-EcoRI fragment of the resultant 
plasmid was transferred to pLGT2 by corresponding fragment ex- 
change in order to construct pLGS65C/D66A. The S65C/R70A double 
mutant was constructed in a similar manner to the S65C/D66A mutant 
using pERS65C, as a template, and a synthetic primer, 5'-GATTTG- 
GAGCTCGCCCAGTGC-3', which contains mismatches causing a 
Arg-70--*Ala mutation and silent mismatches generating a Sacl site, 
and reconstructed to pLGS65C/R70A by fragment exchange. The mu- 
tation was detected as the appearance of the Sacl site. Finally, the 
D66C single mutant was constructed using pCTI 183, as a template, and 
a synthetic oligomer having the complementary sequence of 5'-ACC- 
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AAATCTGCAGGACATTTT-3', which contains mismatches causing 
a Asp-66 ~ Cys mutation and generating a PstI site. The mutation was 
detected as the appearance of the PstI site and, after DNA sequencing, 
pLGD66C was constructed by corresponding fragment exchange. 
2.4. Preparation of inverted membrane vesicles and transport assaying 
Inverted membrane vesicles were prepared from Escherichia coli 
W3104 [12] cells carrying pLGT2 or its derivatives encoding TetA(B) 
mutants, as described previously [5]. [3H]Tetracycline uptake by in- 
verted membrane vesicles was assayed in the presence of 10/~M [3H]te- 
tracycline and 50/tM CoC12 in 50 mM MOPS-KOH buffer (pH 7.0) 
containing 0.1 M KCI [13]. 
2.5. Assaying of the reaction of [14C]N-ethylmaleimide with TetA (B) 
proteins 
Inverted membrane vesicles (0.5 mg protein) were incubated in 100 
/.tl of 50 mM MOPS-KOH buffer (pH 7.0) containing 0.1 M KCI, 5 mM 
MgSO 4 and 0.5 mM [~4C]NEM at 30°C for 1 rain or 5 min in the 
presence or absence of 1 mM tetracycline. When the vesicles were 
energized, they were pretreated with 50 mM NADH for 1 min at 30°C 
prior to the addition of [J4C]NEM and tetracycline. Immediately after 
the incubation with [~4C]NEM, the vesicles were diluted with 900/ll of 
50 mM MOPS-KOH buffer (pH 7.0) containing 0.1 M KC1 and excess 
unlabeled NEM (10 raM) to stop the reaction. Then the vesicles were 
precipitated by ultracentrifugation at 200,000 x g for 30 min at 4 °C in 
a Beckman ultracentrifuge, Optima TL. The resultant precipitate was 
solubilized in 200/11 of 10 mM sodium phosphate buffer (pH 7.4) 
containing 0.1 M NaC1, 1% Triton X-100, 0.1% SDS and 5 mM unla- 
beled NEM by brief sonication in a Branson bath sonifier. Insoluble 
substances were removed by ultracentrifugation at 200,000 × g for 30 
rain at 4°C. The resultant supernatant was mixed with 15/tl of anti- 
TetA-carboxyl-terminal antiserum [14] in an Eppendorf tube, followed 
by incubation at room temperature for 1 h with shaking. Then 120 ~1 
of a Pansorbin S. aureus cell suspension (Carbiochem) [15] was added 
to the mixture and the incubation was continued for a further 1 h. The 
immunoprecipitate was collected by centrifugation at 1,000 × g for 10 
min at room temperature, and then washed twice with 10 mM sodium 
phosphate buffer (pH 7.4) containing 0.1 M NaCI, 1% Triton X-100 
and 0.1% SDS. SDS gel electrophoresis of the precipitate was per- 
formed, and the radioactive band was visualized by fluorography and 
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Fig. 1. The effect of Mg-tetracycline on the [~4C]NEM binding to 
TetA(B) mutants. Inverted membrane vesciles (0.5 mg protein) contain- 
ing the $65C, S65C/D66A, S65C/R70A for D66C mutant TetA(B) 
protein were incubated with 0.5 mM [t4C]NEM in the absence or pres- 
ence of I mM tetracycline and 5 mM MgSO4 at 30°C for 1 min (A) or 
5 min (B). The binding reaction was terminated by the addition of 
excess non-radioactive NEM, followed by solubilization and im- 
munoprecipitation f the TetA(B) proteins as described in section 2. 
After SDS-PAGE, the yield gels were exposed to X-ray film for 40 days 
at -80°C. - and + indicate the absence and presence of Mg-tetracy- 
cline, respectively. 
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Fig. 2. The effect of membrane energization on the [~4C]NEM binding 
to the $65C mutant TetA(B). After 1 rain preincubation with or without 
50 mM NADH, inverted membrane vesicles (0.5 mg protein) containing 
the $65C mutant TetA(B) were incubated with 0.2 mM [~4C]NEM in 
the absence or presence of 2 mM tetracycline at 30°C for 5 min. 
Radioactive bands were visualized as described in Fig. 1. 
3. Results and discussion 
3.1. Effect of  tetracycline on the reaction of  F4C]NEM with 
the $65C mutant TetA(B) protein 
Inverted membrane vesicles containing the $65C mutant 
TetA(B) proteins were incubated with 0.5 mM [14C]NEM for 
1 min or 5 min in the absence or presence of 1 mM tetracycline 
and 5 mM MgSO 4. After stopping the reaction of [14C]NEM 
by the addition of excess non-radioactive NEM, the vesicles 
were solubilized with detergents, followed by immunoprecipita- 
tion of TetA(B) proteins with an anti-C-terminal ntibody [14]. 
[t4C]NEM-bound TetA(B) proteins were detected by autoradi- 
ography after SDS-PAGE and quantitated with a Bioimaging 
Analyzer BAS2000 (Fuji Film Co., Tokyo). As shown in Fig. 
I A, the degree of the [~4C]NEM reaction with the $65C mutant 
after 1 rain incubation in the presence of Mg-tetracycline was 
at least 2-fold higher than that in the absence of the substrate. 
The ratio of the degree of the reaction in the presence of tetra- 
cycline to that in its absence was roughly maintained after 5 min 
incubation (Fig. IB), although the degree of the reaction in 
both cases increased uring this period. Therefore, the effect 
of Mg-tetracycline was on the rate of the reaction of [~4C]NEM 
with the $65C mutant, suggesting that the substrate-induced 
conformational change of the TetA(B) protein caused the expo- 
sure of the SH group of Cys-65 to the medium. 
In the previous paper [1], we reported that the reaction of 
[HC]NEM with the $65C mutant was inhibited by tetracycline, 
however, the previous observation was a mistake due to the 
unexpected loss of the TetA protein during immunoprecipita- 
tion after tetracycline treatment. In the present study, each 
experiment was performed at least twice, and the immunopre- 
cipitated TetA proteins were detected with Coomassie brilliant 
blue staining after SDS-PAGE of aliquots of each sample. In 
addition, the acceleration of the reaction was reproducibly ob- 
served in the different concentrations of tetracycline. 
As a control, the effect of Mg-tetracycline on the reaction of 
[HC]NEM with the D66C mutant was investigated. Although 
Cys-66 is the residue next to Ser-65, the reaction with the 
former was not affected by Mg-tetracycline (Fig. 1A and B). 
The D66C mutant has no tetracycline transport activity (data 
not shown), probably due to the lack of interaction with Mg- 
tetracycline. It is interesting that the rate of the reaction with 
the D66C mutant was much higher than that to the $65C 
mutant, indicating that the side chain at position 66 is suffi- 
ciently exposed to the medium. 
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Fig. 3. The effect of magnesium ions on the [L4C]NEM binding to the 
$65C mutant TetA(B). Inverted membrane vesicles (0.5 mg protein) 
were incubated with 0.2 mM [14C]NEM in the presence or absence of 
1 mM tetracycline, with or without 5 mM MgSO 4, at 30°C for 5 min. 
Radioactive bands were visualized with a Bioimaging Analyzer 
BAS2000. 
3.2. Effect of mutations at Asp-66 and Arg-70 on the substrate- 
accelerated reaction of [14C]NEM with Cys-65 
Asp-66 of the $65C mutant TetA(B) was replaced by a neu- 
tral residue, alanine, by site-directed mutagenesis. As shown in 
Fig. 1, the reaction of ['4C]NEM with the resulting double 
mutant, S65C/D66A, was no longer affected by the presence of 
Mg-tetracycline. Irrespective of the presence of tetracycline, the 
degree of the reaction with the S65C/D66A double mutant was 
intermediate b tween those to the $65C mutant with and with- 
out tetracycline. This finding indicated that the conformational 
change of the Cys-65 locus is probably due to the interaction 
of Mg-tetracycline with the negatively-charged carboxyl side 
chain of Asp-66. The replacement of Asp-66 with a neutral 
residue may fix the protein conformation between the confor- 
mations in the absence and presence of the substrate. 
On the other hand, the substrate-induced acceleration of the 
reaction did not disappear on the replacement of Arg-70 by 
Ala, which is another important charged residue in loop2 3 [2]. 
On the contrary, the degree of acceleration of the reaction 
appeared to be increased in the S65C/R70A double mutant, 
mainly due to the very low reactivity of the double mutant with 
NEM in the absence of tetracycline. There are two possibilities 
for such low reactivity, one is that the Cys-65 locus was more 
cryptic in the S65C/R70A double mutant than that in the $65C 
single mutant in the absence of the substrate or the other is that 
the basic side chain of Arg-70 facilitates deprotonation f Cys- 
65. In the latter case, Arg-70 may be sterically close to Cys-65 
at least in the absence of the substrate. Anyway, it is clear that 
Arg-70 does not directly contribute to the substrate-induced 
conformational change of the Cys-65 locus. 
The R70A and S65C/R70A mutants maintained very low 
tetracycline transport activity, i.e. about 3% of the wild type 
level, whereas the D66A and S65C/D66A mutants had no activ- 
ity (data not shown). The loss of activity of the latter mutants 
is probably due to the lack of the substrate-protein interaction. 
In contrast, although the conformational change induced by 
the substrate-protein interaction was maintained in the former 
mutants, the transport activity was drastically decreased, prob- 
ably due to the hindrance of the substrate translocation step 
after the initial substrate protein interaction. 
3.3. The eff~ct o]membrane nergization on the substrate- 
induced acceleration of the [14C]NEM reaction 
TetA(B)-mediated tetracycline transport is driven by a pro- 
ton motive force [16,17]. If the substrate-induced conforma- 
tional change of the Cys-65 locus is a process of the substrate 
translocation reaction, it may be affected by a proton motive 
force. To investigate this possibility, inverted membrane vesi- 
cles were energized by NADH-dependent respiration prior to 
the addition of [14C]NEM and tetracycline. As shown in Fig. 
2, the substrate-accelerated reaction was really further stimu- 
lated by the addition of NADH. This finding suggests that the 
exposure of the Cys-65 locus is one of the processes of the 
substrate translocation reaction subsequent to the initial sub- 
strate-Asp-66 interaction. 
3.4. The divalent cation requirement for the acceleration of the 
[14C]NEM reaction with the substrate 
The real substrate of TetA(B) is a Mg-tetracycline chelation 
complex [13]. As shown in Fig. 3, the acceleration of the reac- 
tion of [14C]NEM with the $65C mutant with tetracycline was 
not observed if magnesium ions were not added. The magne- 
sium ion itself did not affect the degree of the reaction of 
[~4C]NEM in the absence of tetracycline. This observation also 
confirms that the tetracycline-induced acceleration of the reac- 
tion of [14C]NEM is due to the conformational change accom- 
panying the initial substrate-protein interaction i  the trans- 
port process. 
The findings reported in this paper indicate that the confor- 
mational change in the 1oop2-3 locus induced on the interac- 
tion of Asp-66 with Mg-tetracycline is an initial step of the 
tetracycline translocation reaction. 
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